MedDataX Logo

Standard Length Catheters vs Long Catheters in Peripheral Vein Cannulation.

NCT ID: NCT01917253

Last Updated: 2013-08-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

220 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-09-30

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Long and Short is a prospective, randomized, controlled, open label trial to test the complications of different device for peripheral vein cannulation, standard length (about 5 cm in length) and long catheter (about 12 cm in length), inserted with Seldinger technique.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The trial will compare the main complications: infiltration rate, phlebitis rate, occlusion and/or dislocation rate, thrombosis rate, number of percutaneous sticks, successful cannulation.

Will be made for a cost analysis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Complications

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

infiltration, phlebitis, occlusion, thrombosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

standard length catheter

Standard Device for peripheral vein cannulation

Group Type EXPERIMENTAL

Standard Device for peripheral vein cannulation

Intervention Type DEVICE

Long catheter

Standard Device for peripheral vein cannulation

Group Type EXPERIMENTAL

Long Catheters for peripheral vein cannulation

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard Device for peripheral vein cannulation

Intervention Type DEVICE

Long Catheters for peripheral vein cannulation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult patients
* infusional therapy more than 72 hours

Exclusion Criteria

* need for central venous catheter
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

ASL TO2 Torino

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tiziana De Prospo

Nurse

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Piero Riva, MD

Role: PRINCIPAL_INVESTIGATOR

ASLTO2- MECAU- Maria Vittoria Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

MECAU-Maria Vittoria Hospital

Torino, Torino, Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tiziana De Prospo

Role: CONTACT

Phone: +39 011 439

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Piero Riva, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

351/007A/2013

Identifier Type: -

Identifier Source: org_study_id